Rasna Therapeutics, Inc. Stock Other OTC
Equities
RASP
US7538881068
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 15.44M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | -4M | EV / Sales 2022 | - |
Net Debt 2022 | 180K | Net Debt 2023 | 136K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
-2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 14.81% |
Managers | Title | Age | Since |
---|---|---|---|
Keeren Shah
DFI | Director of Finance/CFO | 47 | 16-06-30 |
Jules S. Jacob
PRN | Corporate Officer/Principal | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 16-07-31 |
Willy Simon
CHM | Chairman | 72 | 20-10-13 |
Gary Jacob
BRD | Director/Board Member | 77 | 20-12-22 |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 121B | |
+17.75% | 110B | |
+17.23% | 25.98B | |
-24.11% | 19.27B | |
-18.56% | 15.99B | |
-18.47% | 15.66B | |
-47.75% | 14.5B | |
+57.35% | 14.47B | |
+5.62% | 13.91B |